Vr Adviser, LLC Oric Pharmaceuticals, Inc. Transaction History
Vr Adviser, LLC
- $606 Million
- Q4 2024
A detailed history of Vr Adviser, LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 4,394,527 shares of ORIC stock, worth $36.7 Million. This represents 5.85% of its overall portfolio holdings.
Number of Shares
4,394,527
Previous 4,394,527
-0.0%
Holding current value
$36.7 Million
Previous $45 Million
21.27%
% of portfolio
5.85%
Previous 4.67%
Shares
3 transactions
Others Institutions Holding ORIC
# of Institutions
129Shares Held
69.1MCall Options Held
387KPut Options Held
700-
Nextech Invest Ag5.29MShares$44.2 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$40.4 Million0.0% of portfolio
-
Viking Global Investors LP4.43MShares$37 Million0.12% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$34.6 Million2.29% of portfolio
-
Alkeon Capital Management LLC New York, NY3.9MShares$32.6 Million0.07% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $331M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...